|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.54 USD | -2.31% |
|
+14.93% | +71.62% |
| 01/07 | Cardiff Oncology, Inc.(NasdaqCM:CRDF) added to Russell Small Cap Comp Value Index | CI |
| 01/07 | Cardiff Oncology, Inc.(NasdaqCM:CRDF) added to Russell Small Cap Completeness Index | CI |
Company Overview
The Onvansertib Opportunity
S G2
TUMOR
CELL CYCLE
G1 M
S | G2 |
TUMOR
CELL CYCLE
G1 M
•
•
•
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
Disclaimer
Cardiff Oncology Inc. published this content on 07 January 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 07 January 2022 02:17:04 UTC.
| 1st Jan change | Capi. | |
|---|---|---|
| +71.62% | 12Cr | |
| +24.74% | 4.8TCr | |
| -0.47% | 4.24TCr | |
| +43.96% | 4.15TCr | |
| +25.40% | 3.16TCr | |
| +17.96% | 2.86TCr | |
| -4.47% | 2.8TCr | |
| +50.73% | 1.46TCr | |
| +42.56% | 1.41TCr | |
| +1.46% | 1.26TCr |
CARDIFF ONCOLOGY, INC. 
